GlassScriptPhysician profile
Payam Moazzaz
NPI 1538304704
$487,493.50
in general payments reported to CMS, 2019-2025
24 companies · $69K in 2025
The $69K reported for 2025 was more than what 90% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81K · 2020: $62K · 2021: $66K · 2022: $62K · 2023: $77K · 2024: $71K · 2025: $69K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $170K · Consulting Fee: $41K · Travel and Lodging: $3,427 · Food and Beverage: $1,745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $170,459.60 |
| Consulting Fee | $40,901.50 |
| Travel and Lodging | $3,427.01 |
| Food and Beverage | $1,744.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyocera Medical Technologies, INC. | $224,102.37 | 2020-2025 | |
| Stryker Corporation | $123,079.71 | 2019-2025 | Cascadia Interbody System, N/A |
| Alphatec Spine, INC | $48,827.20 | 2019-2024 | Battalion Llif |
| Renovis Surgical Technologies, INC. | $48,257.37 | 2019 | |
| Vb Spine LLC | $27,157.09 | 2025 | Cascadia Interbody System, Vulcan Spinal System, Napa Access System |
| Novapproach Spine, LLC | $8,222.15 | 2023-2024 | Onelif |
| Baxter Healthcare | $4,620.68 | 2019 | |
| Boston Scientific Corporation | $1,854.24 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $262.97 | 2023-2025 | Eterna, Penta, Proclaim |
| Medtronic, INC. | $241.02 | 2021-2025 | Cd Horizon Spinal System, Mazor X System |
| Si-Bone, INC. | $225.83 | 2019-2023 | |
| Centinel Spine, LLC | $145.30 | 2022 | |
| Medtronic USA, INC. | $135.00 | 2019 | |
| Nuvasive, INC. | $127.69 | 2019 | |
| Zimmer Biomet Holdings, INC. | $33.95 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $33.95 | 2022 | |
| Solventum Corporation | $31.21 | 2025 | Prevena |
| Integrity Implants INC. Dba Accelus | $30.45 | 2023 | |
| Vision Quest Industries INC. | $29.87 | 2024 | Oactive Align Custom R, Avid Ct2 Nmes/Ifc Stimulator |
| Kerecis Limited | $17.97 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Djo, LLC | $17.23 | 2022 | |
| Kci USA, INC. | $13.74 | 2021 | |
| Elevate Surgical Co | $13.64 | 2025 | |
| Mml US, INC. | $12.87 | 2023 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$13,357.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Payam Moazzaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.